Vanda Pharmaceuticals (NASDAQ:VNDA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Vanda Pharmaceuticals beat estimated earnings by 50.0%, reporting an EPS of $0.12 versus an estimate of $0.08.
Revenue was up $366.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 14.05% drop in the share price the next day.
Here’s a look at Vanda Pharmaceuticals’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.16 | 0.14 | 0.15 | 0.14 |
| EPS Actual | 0.14 | 0.17 | 0.15 | 0.15 |
| Revenue Estimate | 75.00M | 69.75M | 68.50M | 64.00M |
| Revenue Actual | 70.09M | 67.90M | 62.67M | 67.65M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
